We are live on ! Find out more
OLMA icon

Olema Pharmaceuticals
OLMA

122 hedge funds and large institutions have $301M invested in Olema Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 57 increasing their positions, 27 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 27

21% more capital invested

Capital invested by funds: $248M → $301M (+$52.5M)

6.64% more ownership

Funds ownership: 96.44% → 103.08% (+6.6%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

8% less funds holding

Funds holding: 133 → 122 (-11)

10% less call options, than puts

Call options by funds: $202K | Put options by funds: $225K

38% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 29

Holders
122
Holders Change
-11
Holders Change %
-8.27%
% of All Funds
1.61%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
57
Reduced
27
Closed
29
Calls
$202K
Puts
$225K
Net Calls
-$23K
Net Calls Change
+$78K

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$13.5M
2
WP
Woodline Partners
California
+$9.04M
3
Morgan Stanley
Morgan Stanley
New York
+$4.39M
4
BlackRock
BlackRock
New York
+$3.49M
5
Ameriprise
Ameriprise
Minnesota
+$3.45M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$5.55M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.42M
3
MB
MPM BioImpact
Massachusetts
-$2.46M
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$1.61M
5
Marshall Wace
Marshall Wace
United Kingdom
-$1.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
Balyasny Asset Management
126
Balyasny Asset Management
Illinois
– -$425K -113,018 Closed
DIA
127
Dana Investment Advisors
Wisconsin
– -$425K -112,954 Closed
CSS
128
Cubist Systematic Strategies
Connecticut
– -$352K -93,669 Closed
Walleye Capital
129
Walleye Capital
New York
– -$330K -87,705 Closed
OAM
130
Oxford Asset Management
United Kingdom
– -$259K -68,974 Closed
BFM
131
Boothbay Fund Management
New York
– -$217K -57,824 Closed
Envestnet Asset Management
132
Envestnet Asset Management
Illinois
– -$176K -46,699 Closed
GCM
133
Graham Capital Management
Connecticut
– -$175K -46,510 Closed
Verition Fund Management
134
Verition Fund Management
Connecticut
– -$94.5K -25,125 Closed
Mirae Asset Global ETFs Holdings
135
Mirae Asset Global ETFs Holdings
Hong Kong
– -$90K -23,932 Closed
CC
136
Corton Capital
Ontario, Canada
– -$81.7K -21,741 Closed
CF
137
Corebridge Financial
Texas
– -$75.3K -20,026 Closed
SSA
138
Schonfeld Strategic Advisors
New York
– -$75.3K -20,020 Closed
SG Americas Securities
139
SG Americas Securities
New York
– -$53K -14,193 Closed
AGM
140
Alpine Global Management
New York
– -$52.2K -13,874 Closed
AI
141
Atom Investors
Texas
– -$50.8K -13,499 Closed
P
142
Pitcairn
Pennsylvania
– -$47.1K -12,532 Closed
JG
143
Jain Global
New York
– -$46.6K -12,396 Closed
QL
144
Quarry LP
New York
– -$45.1K -12,000 Closed
YIH
145
Y-Intercept (HK)
Hong Kong
– -$40.9K -10,882 Closed
PD
146
Point72 (DIFC)
United Arab Emirates
– -$32.2K -8,572 Closed
NS
147
NBC Securities
Alabama
– -$4K -1,248 Closed
CIAM
148
Caitong International Asset Management
Hong Kong
– -$1.82K -484 Closed
CA
149
CoreCap Advisors
Michigan
– -$936 -249 Closed
CCM
150
Coldstream Capital Management
Washington
– -$854 -227 Closed
3 4 5
6
7

OLMA Hedge Fund Activity: Q2 2025 in Review

122 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q2 2025, worth a combined $301M — up 21% from $248M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of OLMA and 18 opened new positions — a net loss of 11 holders — while 27 trimmed existing stakes and 57 added.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $13.5M. The largest seller was Wellington Management Group, cutting an estimated $5.55M.

  • 122 institutional investors held Olema Pharmaceuticals (OLMA) as of Q2 2025, down from 133 in Q1 2025.
  • Funds reported $301M of Olema Pharmaceuticals stock for Q2 2025, up 21% quarter-over-quarter.
  • 18 funds opened new Olema Pharmaceuticals positions in Q2 2025 and 29 closed out, a net change of -11 holders.
  • The largest Olema Pharmaceuticals buyer in Q2 2025 was Janus Henderson Group, an estimated $13.5M added.
  • The largest Olema Pharmaceuticals seller in Q2 2025 was Wellington Management Group, an estimated $5.55M sold.

Based on aggregated 13F filings for Q2 2025.